BOSTON, US: Oral lichen planus and recurrent aphthous stomatitis are common chronic inflammatory conditions that can affect patients’ quality of life. Since current treatment approaches are mainly palliative and often ineffective owing to insufficient contact time of the therapeutic agent with the lesions, researchers have recently developed an adhesive patch to improve retention in the oral cavity and enable sustained release of clobetasol-17-propionate, the first-line drug for treating both conditions.
In the study, the researchers—from the Harvard School of Dental Medicine in Boston—also examined the properties of the novel bio-inspired adhesive patch, called Dental Tough Adhesive (DenTAl), regarding adhesion to diverse oral tissues. They subjected DenTAl to ex vivo mechanical testing, assessed its biocompatibility in vitro and adhesion in vivo and ex vivo, and investigated its drug release in vitro when loaded with clobetasol.
They found that DenTAl has superior physical, such as stretchability, and adhesive properties compared with existing oral technologies and is capable of strong adhesion to different kinds of wet and dynamic intra-oral tissue. They also reported that the clobetasol was released in a tunable sustained manner for up to four weeks and demonstrated immunomodulatory capabilities in vitro, resulting in reductions in several pro-inflammatory cytokines.
The study’s findings suggest that DenTAl may be a promising device for the intra-oral delivery of small-molecule drugs for the management of painful oral lesions associated with chronic inflammatory conditions such as oral lichen planus and recurrent aphthous stomatitis. The researchers said that future clinical applications may include delivery of antimicrobial and chemotherapeutic agents to treat periodontitis and precancerous or malignant lesions.
The study, titled “Tough adhesive hydrogel for intraoral adhesion and drug delivery”, was published online on 8 March 2023 in the Journal of Dental Research, ahead of inclusion in an issue.
Tags:
LOUISVILLE, Ky., US: Researchers from the US have recently examined the role that oral microbes play in regulating antiviral responses in the oral cavity. ...
Dr Dominik Nischwitz is a dentist and naturopath, a world specialist in biological dentistry and ceramic implants, and the vice-president of the ...
QINGDAO, China: Most adults experience episodes of gingivitis, which can progress to periodontitis, yet the role of plaque in gingivitis onset and ...
LOS ANGELES, U.S.: The link between periodontal disease and systemic conditions such as cardiovascular disease is, by now, well established in the ...
LOS ANGELES, U.S.: In a recent study, researchers examined the effect that APG-157, a botanical plant-based drug that contains curcumin and was developed ...
VALENCIA, Spain: Studies on the effects that alcohol, tobacco and caffeine have on the biological and microbiological status of the oral cavity have shown ...
SEOUL, South Korea: Ethanol extracts of the fruit of the Terminalia chebula tree, commonly known as Indian walnut, may be an effective means to prevent oral...
BIRMINGHAM, UK: In a recent study, researchers from the University of Birmingham examined the records of patients having a history of periodontal disease, ...
Live webinar
Thu. 18 July 2024
8:00 PM EST (New York)
Live webinar
Tue. 6 August 2024
6:00 PM EST (New York)
Live webinar
Tue. 13 August 2024
7:00 PM EST (New York)
Live webinar
Wed. 14 August 2024
12:30 PM EST (New York)
Live webinar
Wed. 21 August 2024
9:00 AM EST (New York)
Dr. Jim Lai DMD, MSc(Perio), EdD, FRCD(C)
Live webinar
Wed. 28 August 2024
8:00 PM EST (New York)
Live webinar
Mon. 2 September 2024
5:00 AM EST (New York)
To post a reply please login or register